骨接合インプラント市場調査レポート情報：製品別（スクリューとプレート、ワイヤーとピン、髄内ロッドとネイル、脊椎固定装置）、材料別（ステンレス鋼、チタンとチタン合金、生体吸収性ポリマー、その他）、骨折タイプ別（股関節骨折、膝関節骨折、脊椎骨折、肩関節骨折、その他）、エンドユーザー別（病院、整形外科クリニック、外来手術センター）、地域別（北米、欧州、アジア太平洋、その他地域） 2032年までの予測
Osteosynthesis Implants Market Research Report Information By Product (Screws and Plates, Wires and Pins, Intramedullary Rods and Nails, and Spinal Fixation Devices), By Material (Stainless Steel, Titanium and Titanium Alloys, Bioabsorbable Polymers, and Others), By Fracture Type (Hip Fracture, Knee Fracture, Spine Fracture, Shoulder Fracture, and Others), By End User (Hospitals, Orthopaedic Clinics, and Ambulatory Surgical Centers) and by Region (North America, Europe, Asia-Pacific, and Rest of the World) Forecast till 2032
骨接合インプラント市場調査レポート情報：製品別（スクリューとプレート、ワイヤーとピン、髄内ロッドとネイル、脊椎固定装置）、材料別（ステンレス鋼、チタンとチタン合金、生体吸収性ポリマー、その他）、骨... もっと見る
サマリー 骨接合インプラント市場調査レポート情報：製品別（スクリューとプレート、ワイヤーとピン、髄内ロッドとネイル、脊椎固定装置）、材料別（ステンレス鋼、チタンとチタン合金、生体吸収性ポリマー、その他）、骨折タイプ別（股関節骨折、膝関節骨折、脊椎骨折、肩関節骨折、その他）、エンドユーザー別（病院、整形外科クリニック、外来手術センター）、地域別（北米、欧州、アジア太平洋地域、その他地域）：2032年まで予測
市場概要
骨接合インプラント市場は、2024年の56.7億米ドルから2032年には96.6億米ドルまで、年平均成長率（CAGR）6.99%を記録すると予測される。
骨接合インプラントの世界市場は、世界的な骨折の有病率の増加と骨粗鬆症の罹患率の上昇によって牽引されている。とはいえ、世界市場は骨接合インプラントに関連する合併症によって制約を受けると予想される。しかし、世界的な高齢者人口の増加、進行中の臨床試験、技術進歩の加速により、市場は収益機会を生み出すと予想される。
骨折の管理は、骨密度の低下と脆弱性の増大によって定義される骨粗鬆症によって著しく複雑になる。骨粗鬆症は、特に股関節、脊椎、手首のような体重を支える骨において骨折の可能性を高める。骨粗鬆症の骨における骨折は、骨質が低下し機械的安定性が低下する結果、特有の障害をもたらすことが多い。骨接合インプラントは、骨折の治癒を促進し、機械的支持を提供するため、骨粗鬆症患者の骨折治療には不可欠です。
市場セグメントの洞察
世界の骨接合インプラントを製品別に分類すると、スクリューとプレート、ワイヤーとピン、髄内ロッドとネイル、脊椎固定装置となる。
ステンレス鋼、チタンおよびチタン合金、生体吸収性ポリマー、その他の材料が市場の細分化を構成している。
市場は、股関節骨折、膝関節骨折、脊椎骨折、肩関節骨折、その他など、骨折の種類によって細分化されている。
病院、整形外科クリニック、外来手術センターが骨接合インプラント市場を構成しており、エンドユーザー別に細分化されている。
地域別展望
2022年には、北米のオステオシンセシスインプラントが39.76%で最大の市場シェアを占めた。予測期間中に年平均成長率（CAGR）6.33％で成長し、2032年には約39.8億米ドルに達すると予測されている。とはいえ、予測期間中の年平均成長率（CAGR）は欧州が7.35％と最も大きくなると予測されている。
北米のオステオシンセシスインプラント市場は持続的な成長が見込まれ、これは有望な発展である。オステオシンセシスインプラント市場は、外傷やスポーツ傷害の発生率の高さ、整形外科的介入件数の増加、卓越した医療インフラと施設を特徴としている。
欧州の骨接合インプラント市場は現在大きな成長を遂げており、その原動力となっているのは複合的な要因である。これらの要因には、骨粗鬆症の有病率の増加、スポーツ傷害の増加、外科的介入の利点に対する患者の意識の高まりなどが含まれる。
2022年、アジア太平洋地域の骨合成インプラント市場は9億9000万米ドルと評価され、予測期間中に5.13%の複合年間成長率（CAGR）で拡大すると予測されています。さらに、急速な人口増加と発展途上国における医療インフラの拡大が、市場の拡大をさらに後押ししている。
2022年のその他の地域のオステオシンセシスインプラント市場規模は7.1億米ドルで、予測期間中に年平均成長率（CAGR）2.76％で拡大すると予測される。中東、アフリカ、中南米が世界の残りの地域を構成している。
主要プレイヤー
Medartis AG、Dieter Marquardt Medizintechnik GmbH、Lepu Medical Technology (Beijing)Co., Ltd.、Globus Medical, Inc.、Zimmer Biomet、Arthrex, Inc.、Precision Spine, Inc.、Johnson & Johnson Services, Inc.、CONMED Corporation、Braun SEなどが骨接合インプラント市場の主要企業である。
ページTOPに戻る
目次 目次
2.
2.
2.
2.
3.
3.
3.
3.
3.
3.
3.
3.
3.
3.
3.
3.
3.
3.
3.
3.
3.
4.
4.
4.
4.
4.
4.
4.
4.
4.
5.
5.
5.
5.
5.
5.
5.
6.
6.
6.
6.
6.
7.
7.
7.
7.
7.
8.
8.
8.
8.
8.
8.
9.
9.
9.
9.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
10.
11.
11.
11.
11.
11.
11.
11.
11.
11.
12.
12.
12.
12.
12.
12.
12.
12.2 JOHNSON & JOHNSON SERVICES, INC.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.4 グロバス・メディカル............................................................................................................................................ 121
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.6 アスレックス
12.
12.
12.
12.
12.
12.7 プレシジョン・スパイン
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.
12.139
12.139
12.
12.
12.
12.10 楽普医療技術（北京）有限公司
12.
12.
12.
12.
12.
12.
ページTOPに戻る
Summary Osteosynthesis Implants Market Research Report Information By Product (Screws and Plates, Wires and Pins, Intramedullary Rods and Nails, and Spinal Fixation Devices), By Material (Stainless Steel, Titanium and Titanium Alloys, Bioabsorbable Polymers, and Others), By Fracture Type (Hip Fracture, Knee Fracture, Spine Fracture, Shoulder Fracture, and Others), By End User (Hospitals, Orthopaedic Clinics, and Ambulatory Surgical Centers) and by Region (North America, Europe, Asia-Pacific, and Rest of the World) Forecast till 2032
Market Overview
The Osteosynthesis Implants Market is anticipated to experience a compound annual growth rate (CAGR) of 6.99% from USD 5.67 Billion in 2024 to USD 9.66 Billion by 2032.
The global osteosynthesis implant market is being driven by the increasing prevalence of fractures and the rising incidence of osteoporosis worldwide. Nevertheless, the global market is anticipated to be constrained by the complications associated with osteosynthesis implants. However, the market is expected to generate profitable opportunities because of the global elderly population, ongoing clinical trials, and the acceleration of technological advancements.
The management of fractures is significantly complicated by osteoporosis, which is defined by a reduction in bone density and an increase in fragility. Osteoporosis increases the likelihood of fractures, particularly in weight-bearing bones like the hip, spine, and wrist. Fractures in osteoporotic bones frequently pose distinctive obstacles as a result of compromised bone quality and diminished mechanical stability. Osteosynthesis implants are essential in the treatment of fractures in osteoporotic patients, as they facilitate fracture healing and provide mechanical support.
Market segment insights
The segmentation of global osteosynthesis implants by product, screws and plates, wires and pins, intramedullary rods and nails, and spinal fixation devices.
Stainless steel, titanium and titanium alloys, bioabsorbable polymers, and other materials comprise the market segmentation.
The market has been segmented according to the type of fracture, including hip fracture, knee fracture, spine fracture, shoulder fracture, and others.
Hospitals, orthopedic clinics, and ambulatory surgical centers comprise the Osteosynthesis Implants Market, which has been segmented by end user.
Regional Perspectives
In 2022, North America Osteosynthesis Implants held the largest market share at 39.76%. It is expected to grow at a compound annual growth rate (CAGR) of 6.33% over the forecast period to reach approximately USD 3.98 billion by 2032. Nevertheless, Europe is anticipated to experience the most significant compound annual growth rate (CAGR) of 7.35% during the forecast period.
The North American Osteosynthesis Implants market is expected to experience sustained growth, which is a promising development. The osteosynthesis implants market is characterized by a high incidence of trauma and sports injuries, a rise in the number of orthopedic interventions, and an exceptional healthcare infrastructure and facilities.
The European Osteosynthesis Implants market is currently experiencing significant growth, which is being driven by a combination of factors. These factors include the increasing prevalence of osteoporosis, the growing number of sports injuries, and the growing awareness of the benefits of surgical intervention among patients.
In 2022, the Asia-Pacific Osteosynthesis Implants market was valued at USD 0.99 billion and is anticipated to expand at a compound annual growth rate (CAGR) of 5.13% over the forecast period. Furthermore, the market's expansion is further bolstered by the rapid population growth and the expanding healthcare infrastructure in developing countries.
In 2022, the Rest of the World Osteosynthesis Implants market was valued at USD 0.71 billion and is anticipated to expand at a compound annual growth rate (CAGR) of 2.76% over the projection period. The Middle East, Africa, and Latin America comprise the remainder of the world.
Major Players
Medartis AG, Dieter Marquardt Medizintechnik GmbH, Lepu Medical Technology (Beijing)Co.,Ltd., Globus Medical, Inc., Zimmer Biomet, Arthrex, Inc., Precision Spine, Inc., Johnson & Johnson Services, Inc., CONMED Corporation., and Braun SE are among the key companies in the osteosynthesis implant market.
ページTOPに戻る
Table of Contents TABLE OF CONTENTS
1 EXECUTIVE SUMMARY ............................................................................................................... 17
2 MARKET INTRODUCTION ............................................................................................................ 19
2.1 DEFINITION .................................................................................................................................................................. 19
2.2 SCOPE OF THE STUDY .............................................................................................................................................. 19
2.3 RESEARCH OBJECTIVE ............................................................................................................................................ 19
2.4 MARKET STRUCTURE .............................................................................................................................................. 19
3 RESEARCH METHODOLOGY ...................................................................................................... 20
3.1 OVERVIEW .................................................................................................................................................................... 20
3.2 DATA FLOW .................................................................................................................................................................. 22
3.2.1 DATA MINING PROCESS ................................................................................................................................. 22
3.3 PURCHASED DATABASE: ......................................................................................................................................... 23
3.4 SECONDARY SOURCES: ............................................................................................................................................ 24
3.4.1 SECONDARY RESEARCH DATA FLOW: ............................................................................................................. 25
3.5 PRIMARY RESEARCH: ............................................................................................................................................... 26
3.5.1 PRIMARY RESEARCH DATA FLOW: ................................................................................................................. 27
3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED ......................................................................... 28
3.6 APPROACHES FOR MARKET SIZE ESTIMATION: ........................................................................................... 29
3.6.1 REVENUE ANALYSIS APPROACH ..................................................................................................................... 29
3.7 DATA FORECASTING................................................................................................................................................. 30
3.7.1 DATA FORECASTING TECHNIQUE .................................................................................................................... 30
3.8 DATA MODELLING ..................................................................................................................................................... 31
3.8.1 MICROECONOMIC FACTOR ANALYSIS: ............................................................................................................ 31
3.8.2 DATA MODELLING: ......................................................................................................................................... 32
3.9 TEAMS AND ANALYST CONTRIBUTION ........................................................................................................... 34
4 MARKET DYNAMICS .................................................................................................................... 36
4.1 INTRODUCTION ........................................................................................................................................................... 36
4.2 DRIVERS ......................................................................................................................................................................... 37
4.2.1 RISING INCIDENCES OF OSTEOPOROSIS ACROSS THE GLOBE .......................................................................... 37
4.2.2 INCREASING INCIDENCE OF FRACTURES ......................................................................................................... 38
4.3 RESTRAINTS ................................................................................................................................................................ 39
4.3.1 COMPLICATIONS ASSOCIATED WITH OSTEOSYNTHESIS IMPLANTS ................................................................ 39
4.4 OPPORTUNITY ............................................................................................................................................................. 40
4.4.1 GROWING TECHNOLOGICAL ADVANCMENTS AND ONGOING CLINICAL TRIALS ................................................ 40
4.4.2 INCREASING ELDERLY POPULATION, WORLDWIDE ........................................................................................... 40
5 MARKET FACTOR ANALYSIS ...................................................................................................... 41
5.1 PORTER'S FIVE FORCES MODEL ........................................................................................................................... 41
5.1.1 THREAT OF NEW ENTRANTS ........................................................................................................................... 41
5.1.2 BARGAINING POWER OF SUPPLIERS ............................................................................................................... 42
5.1.3 THREAT OF SUBSTITUTES .............................................................................................................................. 42
5.1.4 BARGAINING POWER OF BUYERS .................................................................................................................... 42
5.1.5 INTENSITY OF RIVALRY .................................................................................................................................. 42
5.2 IMPACT OF COVID-19 ON THE GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET ............................. 43
6 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, BY PRODUCT ............................................ 45
6.1 OVERVIEW .................................................................................................................................................................... 45
6.2 SCREWS AND PLATES .............................................................................................................................................. 47
6.3 WIRES AND PINS ........................................................................................................................................................ 48
6.4 INTRAMEDULLARY RODS AND NAILS ............................................................................................................... 48
6.5 SPINAL FIXATION DEVICES ................................................................................................................................... 49
7 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, BY MATERIAL ........................................... 50
7.1 OVERVIEW .................................................................................................................................................................... 50
7.2 STAINLESS STEEL ..................................................................................................................................................... 52
7.3 TITANIUM AND TITANIUM ALLOYS .................................................................................................................. 53
7.4 BIOABSORBABLE POLYMERS................................................................................................................................. 53
7.5 OTHERS .......................................................................................................................................................................... 54
8 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, BY FRACTURE TYPE ................................ 55
8.1 OVERVIEW .................................................................................................................................................................... 55
8.2 HIP FRACTURE ............................................................................................................................................................ 57
8.3 KNEE FRACTURE ....................................................................................................................................................... 58
8.4 SPINE FRACTURE ....................................................................................................................................................... 58
8.5 SHOULDER FRACTURE ............................................................................................................................................. 59
8.6 OTHERS .......................................................................................................................................................................... 59
9 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, BY END USER ........................................... 60
9.1 OVERVIEW .................................................................................................................................................................... 60
9.2 HOSPITALS ................................................................................................................................................................... 61
9.3 ORTHOPAEDIC CLINICS ............................................................................................................................................ 62
9.4 AMBULATORY SURGICAL CENTERS ................................................................................................................... 62
10 GLOBAL OSTEOSYNTHESIS IMPLANTS MARKET, BY REGION ............................................... 63
10.1 OVERVIEW .................................................................................................................................................................... 63
10.2 NORTH AMERICA ....................................................................................................................................................... 65
10.2.1 US.................................................................................................................................................................. 68
10.2.2 CANADA ........................................................................................................................................................ 70
10.3 EUROPE .......................................................................................................................................................................... 72
10.3.1 GERMANY ...................................................................................................................................................... 75
10.3.2 FRANCE ......................................................................................................................................................... 76
10.3.3 UK ................................................................................................................................................................. 78
10.3.4 ITALY ............................................................................................................................................................. 79
10.3.5 SPAIN ............................................................................................................................................................ 80
10.3.6 REST OF EUROPE ............................................................................................................................................ 82
10.4 ASIA-PACIFIC ............................................................................................................................................................... 84
10.4.1 CHINA ............................................................................................................................................................ 87
10.4.2 INDIA ............................................................................................................................................................. 88
10.4.3 JAPAN ........................................................................................................................................................... 90
10.4.4 SOUTH KOREA ................................................................................................................................................ 91
10.4.5 AUSTRALIA .................................................................................................................................................... 92
10.4.6 REST OF ASIA-PACIFIC ................................................................................................................................... 94
10.5 REST OF THE WORLD ................................................................................................................................................ 96
10.5.1 MIDDLE EAST & AFRICA .................................................................................................................................. 99
10.5.2 LATIN AMERICA ............................................................................................................................................. 100
11 COMPETITIVE LANDSCAPE ........................................................................................................ 103
11.1 INTRODUCTION ........................................................................................................................................................... 103
11.2 MARKET SHARE ANALYSIS, 2022 ....................................................................................................................... 103
11.3 COMPETITOR DASHBOARD..................................................................................................................................... 104
11.4 PUBLIC PLAYERS STOCK SUMMARY ................................................................................................................. 105
11.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL .............................................................................. 105
11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES ............................................................................................ 106
11.6.1 PRODUCT LAUNCH/ PRODUCT APPROVAL ...................................................................................................... 106
11.6.2 MERGER ......................................................................................................................................................... 107
11.6.3 ACQUISITION ................................................................................................................................................. 107
12 COMPANY PROFILES .................................................................................................................. 108
12.1 B. BRAUN SE ................................................................................................................................................................. 108
12.1.1 COMPANY OVERVIEW ..................................................................................................................................... 108
12.1.2 FINANCIAL OVERVIEW .................................................................................................................................... 109
12.1.3 PRODUCTS OFFERED ...................................................................................................................................... 109
12.1.4 KEY DEVELOPMENTS ...................................................................................................................................... 110
12.1.5 SWOT ANALYSIS ............................................................................................................................................ 111
12.1.6 KEY STRATEGIES ............................................................................................................................................ 111
12.2 JOHNSON & JOHNSON SERVICES, INC. ............................................................................................................... 112
12.2.1 COMPANY OVERVIEW ..................................................................................................................................... 112
12.2.2 FINANCIAL OVERVIEW .................................................................................................................................... 113
12.2.3 PRODUCTS OFFERED ...................................................................................................................................... 113
12.2.4 KEY DEVELOPMENTS ...................................................................................................................................... 115
12.2.5 SWOT ANALYSIS ............................................................................................................................................ 115
12.2.6 KEY STRATEGIES ............................................................................................................................................ 116
12.3 CONMED CORPORATION .......................................................................................................................................... 117
12.3.1 COMPANY OVERVIEW ..................................................................................................................................... 117
12.3.2 FINANCIAL OVERVIEW .................................................................................................................................... 118
12.3.3 PRODUCTS OFFERED ...................................................................................................................................... 118
12.3.4 KEY DEVELOPMENTS ...................................................................................................................................... 119
12.3.5 KEY STRATEGIES ............................................................................................................................................ 120
12.4 GLOBUS MEDICAL, INC. ............................................................................................................................................ 121
12.4.1 COMPANY OVERVIEW ..................................................................................................................................... 121
12.4.2 FINANCIAL OVERVIEW .................................................................................................................................... 122
12.4.3 PRODUCTS OFFERED ...................................................................................................................................... 122
12.4.4 KEY DEVELOPMENTS ...................................................................................................................................... 124
12.4.5 SWOT ANALYSIS ............................................................................................................................................ 125
12.4.6 KEY STRATEGIES ............................................................................................................................................ 125
12.5 ZIMMER BIOMET ........................................................................................................................................................ 126
12.5.1 COMPANY OVERVIEW ..................................................................................................................................... 126
12.5.2 FINANCIAL OVERVIEW .................................................................................................................................... 127
12.5.3 PRODUCTS OFFERED ...................................................................................................................................... 127
12.5.4 KEY DEVELOPMENTS ...................................................................................................................................... 128
12.5.5 SWOT ANALYSIS ............................................................................................................................................ 129
12.5.6 KEY STRATEGIES ............................................................................................................................................ 129
12.6 ARTHREX, INC. ............................................................................................................................................................ 130
12.6.1 COMPANY OVERVIEW ..................................................................................................................................... 130
12.6.2 FINANCIAL OVERVIEW .................................................................................................................................... 130
12.6.3 PRODUCTS OFFERED ...................................................................................................................................... 130
12.6.4 KEY DEVELOPMENTS ...................................................................................................................................... 131
12.6.5 KEY STRATEGIES ............................................................................................................................................ 131
12.7 PRECISION SPINE INC. .............................................................................................................................................. 132
12.7.1 COMPANY OVERVIEW ..................................................................................................................................... 132
12.7.2 FINANCIAL OVERVIEW .................................................................................................................................... 132
12.7.3 PRODUCTS OFFERED ...................................................................................................................................... 132
12.7.4 KEY DEVELOPMENTS ...................................................................................................................................... 133
12.7.5 KEY STRATEGIES ............................................................................................................................................ 133
12.8 MEDARTIS AG .............................................................................................................................................................. 134
12.8.1 COMPANY OVERVIEW ..................................................................................................................................... 134
12.8.2 FINANCIAL OVERVIEW .................................................................................................................................... 135
12.8.3 PRODUCTS OFFERED ...................................................................................................................................... 135
12.8.4 KEY DEVELOPMENTS ...................................................................................................................................... 138
12.8.5 KEY STRATEGIES ............................................................................................................................................ 138
12.9 DIETER MARQUARDT MEDIZINTECHNIK GMBH ........................................................................................... 139
12.9.1 COMPANY OVERVIEW ..................................................................................................................................... 139
12.9.2 FINANCIAL OVERVIEW .................................................................................................................................... 139
12.9.3 PRODUCTS OFFERED ...................................................................................................................................... 139
12.9.4 KEY DEVELOPMENTS ...................................................................................................................................... 141
12.9.5 KEY STRATEGIES ............................................................................................................................................ 141
12.10 LEPU MEDICAL TECHNOLOGY(BEIJING)CO., LTD. .......................................................................................... 142
12.10.1 COMPANY OVERVIEW ..................................................................................................................................... 142
12.10.2 FINANCIAL OVERVIEW .................................................................................................................................... 143
12.10.3 PRODUCTS OFFERED ...................................................................................................................................... 143
12.10.4 KEY DEVELOPMENTS ...................................................................................................................................... 146
12.10.5 SWOT ANALYSIS ............................................................................................................................................ 146
12.10.6 KEY STRATEGIES ............................................................................................................................................ 146
13 DATA CITATIONS ......................................................................................................................... 148
ページTOPに戻る
Market Research Future社の 医療分野 での最新刊レポート
-
抗肥満薬市場調査レポート：治療タイプ別（セロトニン・ノルエピネフリン再取り込み阻害薬、選択的セロトニン2C受容体作動薬、ノルエピネフリン・ドパミン再取り込み阻害薬）、リパーゼ阻害薬、GLP-1受容体作動薬、併用薬、その他）、薬物タイプ別（処方薬、市販薬）、作用機序別（中枢性抗肥満薬、末梢性抗肥満薬）、投与経路別（経口、皮下）、流通チャネル別（病院薬局、小売薬局、オンライン薬局）、地域別（北米、欧州、アジア太平洋、南米、中東、アフリカ） 2035年までの予測
-
ジェネリック医薬品市場調査レポート：適応症別（中枢神経系（CNS）、循環器、泌尿器、腫瘍、呼吸器、その他）、投与経路別（経口、局所、非経口、その他）、流通チャネル別（病院薬局、小売薬局、オンライン薬局）、地域別（北米、欧州、アジア太平洋地域、その他の地域） 2035年までの予測
-
多発性硬化症治療装置市場調査レポート：タイプ別[原発性進行性多発性硬化症（PPMS）、二次性進行性多発性硬化症（SPMS）、再発寛解型多発性硬化症（RRMS）、臨床的孤立症候群（CIS）]、治療装置別[電気刺激装置（機能的電気刺激（FES）、経皮的電気神経刺激（TENS）, 神経刺激装置（脊髄刺激（SCS）, 脳深部刺激（DBS））]、エンドユーザー別（病院＆クリニック, 外来手術センター）、地域別（北米, 欧州, アジア太平洋, 南米, 中東およびアフリカ）2032年までの予測
-
Peptide Cosmetic API Research Report by Application (Anti-Aging & Wrinkle Reduction, Skin Repair & Regeneration, Moisturizing & Hydration, Whitening & Brightening, Hair Care, Anti-Inflammatory & Soothing), by Source (Plant-Derived Peptides, Animal-Derived Peptides, Bioengineered Peptides, Chemically Synthesized), by End-Use Industry (Skincare, Haircare, Injectable Cosmetics, Others), by Region (North America, Europe, APAC, South America, MEA) Forecast till 2035
-
Ischemic Stroke Surgery Market Research Report by Type of Surgery (Thrombectomy, Revascularization Surgery, Carotid Endarterectomy, Angioplasty, Others), by Product Type (Catheters, Aspiration System, Guidewire, Microcatheter, Others), by End-User (Hospitals and Clinics, Ambulatory Surgical Centers, Others), and by Region (North America, Europe, Asia Pacific, Rest of the World) Forecast till 2035
-
アフリカの動物用医薬品市場レポート 動物種別（動物、コンパニオンアニマル）、製品別（医薬品、ワクチン、飼料添加物、衛生用品、診断薬）、流通チャネル別（小売薬局、Eコマース、その他）、地域別（エジプト、ナイジェリア、アルジェリア、チュニジア、リビア、ウガンダ、タンザニア、南スーダン、ケニア、エチオピア、アフリカのその他）の調査レポート情報 2032年までの予測
-
アルテスネート注射剤の世界市場調査レポート：純度別（アルテスネート0.99、アルテスネート0.98）、用途別（マラリア、重症マラリア、脳マラリア、合併症のないマラリア、その他の用途）、エンドユーザー別（病院、診療所、薬局、政府機関、非政府組織）、流通チャネル別（直販、流通業者および卸売業者、小売薬局、オンライン販売）、地域別（北米、欧州、APAC、南米、MEA）2032年までの予測
-
欧州液体クロマトグラフィー機器サービス市場2030年までの予測調査レポート
-
アーユルヴェーダ市場
-
アジア太平洋地域の血液病理学用バイオマーカー市場調査レポート情報：タイプ別（製品・サービス）、癌タイプ別（リンパ腫、白血病）、技術カテゴリー別（NGS、PCR、IHC、FISH、その他）、2032年までの地域別予測
よくあるご質問
Market Research Future社はどのような調査会社ですか?
マーケットリサーチフューチャー（Market Research Future）は世界市場を幅広く調査し、主要分野、地域、国レベルの調査レポートを出版しています。
下記分野については、分野毎に専... もっと見る
調査レポートの納品までの日数はどの程度ですか?
在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。
注文の手続きはどのようになっていますか?
1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。
お支払方法の方法はどのようになっていますか?
納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。
データリソース社はどのような会社ですか?
当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。
|
|
